Dr. Chapman on Targeted Treatments for Non-Traditional Mutations in Melanoma
January 18th 2018Paul B. Chapman, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, professor of medicine at the Weill Cornell Medical College, discusses targeted treatments for non-traditional mutations in melanoma.
Dr. Saltz Discusses FOLFIRINOX in Colorectal Cancer
January 17th 2018Leonard Saltz, MD, executive director for Clinical Value & Sustainability, head, Colorectal Oncology Section, Memorial Sloan Kettering Cancer Center, discusses the option of FOLFIRINOX for the treatment of patients with metastatic colorectal cancer.
Dr. Leitao on the Benefits of Surgery in Ovarian Cancer
November 21st 2017Mario M. Leitao Jr, MD, FACOG, FACS, fellowship director, gynecology service, director, Minimal Access and Robotic Surgery Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, discusses the importance of surgery for patients with ovarian cancer.
Novel Approach Reduces Treatment Toxicities in Patients With HPV-Related Oropharyngeal Cancer
October 5th 2017The incidence of mouth and throat cancer is on the rise due to transmission of the human papilloma virus, but physicians at Memorial Sloan Kettering Cancer Center have managed to significantly reduce the intensity of treatment and improve quality of life for these patients.
Dr. Leitao Discusses Surgery in Gynecologic Malignancies
September 20th 2017Mario M. Leitao, Jr, MD, FACOG, FACS, fellowship director, gynecology service, director, Minimal Access and Robotic Surgery Program, Department of Surgery, Memorial Sloan Kettering Cancer Center, discusses surgery in gynecologic malignancies.
Dr. Hamlin on Future Combination Strategies in the MCL Landscape
September 6th 2017Paul A. Hamlin, MD, medical oncologist, chief, Basking Ridge Medical Oncology Service, Memorial Sloan Kettering Cancer Center, discusses future potential combination strategies in the mantle cell lymphoma (MCL) landscape.